Inclusion Criteria : 
  1.  Any subject newly implanted according to the most recent guidelines from the European Society of Cardiology ( ESC ) for less than10 days with : 
       -  a Single Chamber ( SR ) or a Dual Chamber ( DR ) pacemaker from Microport CRM S. r. l . 
       -  any right atrial and / or right ventricular XFINE lead
  2.  Have reviewed , signed and dated the informed consent
Exclusion Criteria : 
  1.  Included in another clinical study that could confound the results of this study such as studies involving intra - cardiac device
  2.  Contraindication to a maximum single dose of 310 Âµg Dexamethasone Sodium Phosphate ( DSP ) 
  3.  Tricuspid valvular disease or tricuspid replacement heart valve ( mechanical or tissue ) only for subject with DR pacemaker
  4.  Active myocarditis , pocket and / or lead infection
  5.  Age less than 18 years old or under guardianship or kept in detention
  6.  Life expectancy less than 1 year
  7.  Known pregnancy , women breastfeeding or in childbearing age without an adequate contraceptive method
  8.  Be unavailable for the scheduled follow - up associated with this clinical study or refusal to cooperate